Chronic renal failure (CRF) and end stage renal disease (ESRD) are worldwide public health problems and an enormous economic burden. In the United States alone, today 8-10 million individuals suffer from CRF. Cardiovascular disease (CVD) is the most common cause of chronic morbidity and accounts for more than 50% of the deaths in CRF patients. Endothelial dysfunction contributes significantly to CVD and is universal in CRF patients. However, signaling pathways involved in endothelial dysfunction in these patients remain unknown. The proposed research will focus on the role of intracellular signaling in endothelial dysfunction in patients with CRF. The experiments will entail exploration of Wnt signaling pathway in molecular pathogenesis of endothelial dysfunction. Potentially this can be a novel therapeutic strategy and may have porfound benefits in CRF patients.
The specific aims i nclude examining the functions of cultured endothelial cells exposed to uremic serum (serum from patients with ESRD) with modulating Wnt signaling;determining if upregulation of Wnt signaling protects endothelial cells from uremic toxicity in a uremic animal model. This work will be the first detailed functional analysis of the role of signaling pathway in uremia-induced endothelial dysfunction. The applicant is an Instructor in Medicine and is pursing a Ph.D. in the Graduate Program of Molecular Medicine at Boston University School of Medicine in Dr. Herbert T. Cohen's laboratory. He has 6 years experience in basic cellular and molecular biology and 6 months experience in endothelial biology. He is deeply committed to a career centered on basic science in an academic division of Nephrology. Dr. Elazer Edelman, the mentor for PI, is a recognized leader in the field of vascular biology and a Professor in the Department of Medicine at Harvard Medical School. The work will be performed in the thriving research environment of Dr. Edelman's laboratory, home to 90 research scientists and affiliated faculty, located at MIT in the Harvard-MIT Division of Health Sciences and Technology. The combined expertise of the sponsor and collaborators within this thriving environment will provide an outstanding opportunity for the applicant to achieve the goals of the project and to become a successful independent investigator.

Public Health Relevance

These studies may help to delineate a novel role for Wnt signaling in uremia and design further studies to explore both the diagnostic/prognostic and therapeutic benefits of Wnt signaling in CVD in CRF patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK080946-03
Application #
8109265
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2009-07-01
Project End
2014-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
3
Fiscal Year
2011
Total Cost
$149,180
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Shashar, Moshe; Siwak, Jamaica; Tapan, Umit et al. (2016) c-Cbl mediates the degradation of tumorigenic nuclear ?-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors. Oncotarget 7:71136-71150
Shivanna, Sowmya; Kolandaivelu, Kumaran; Shashar, Moshe et al. (2016) The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. J Am Soc Nephrol 27:189-201
Srinivasan, Srimathi; Chitalia, Vipul; Meyer, Rosana D et al. (2015) Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis 18:449-62
Shashar, Moshe; Francis, Jean; Chitalia, Vipul (2015) Thrombosis in the uremic milieu--emerging role of ""thrombolome"". Semin Dial 28:198-205
Voyvodic, Peter L; Min, Daniel; Liu, Robert et al. (2014) Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow. J Biol Chem 289:9547-59
Hartsough, Edward J; Meyer, Rosana D; Chitalia, Vipul et al. (2013) Lysine methylation promotes VEGFR-2 activation and angiogenesis. Sci Signal 6:ra104
Franses, Joseph W; Drosu, Natalia C; Gibson, William J et al. (2013) Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis. Int J Cancer 133:1334-44
Chitalia, Vipul; Shivanna, Sowmya; Martorell, Jordi et al. (2013) c-Cbl, a ubiquitin E3 ligase that targets active ?-catenin: a novel layer of Wnt signaling regulation. J Biol Chem 288:23505-17
Chitalia, Vipul C; Shivanna, Sowmya; Martorell, Jordi et al. (2013) Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127:365-76
Foy, Rebecca L; Chitalia, Vipul C; Panchenko, Maria V et al. (2012) Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1. Hum Mol Genet 21:5456-71

Showing the most recent 10 out of 13 publications